Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ATM |
| Variant | S333F |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | ATM S333F does not lie within any known functional domains of the Atm protein (UniProt.org). S333F complements survival in response to DNA damage in culture but results in reduced phosphorylation of Atm target proteins Chk2 and H2ax and decreased HDR activity in cultured cells (PMID: 35354106), and therefore, is predicted to lead to a loss of Atm protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
ATM mutant ATM inact mut ATM S333F |
| Transcript | NM_000051.4 |
| gDNA | chr11:g.108247060C>T |
| cDNA | c.998C>T |
| Protein | p.S333F |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_006718843 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_006718843.5 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542843 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_005271562.6 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017790.2 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542840.4 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_047426976.1 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017792.2 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542843.2 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| NM_001351834.1 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017789 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| NM_001351834.2 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_005271562.5 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017789.2 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017791.1 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| NM_000051 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_005271562 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| NM_000051.4 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_005271561 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017790.3 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_006718843.4 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542844 | chr11:g.108253957C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017791 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542844.3 | chr11:g.108253957C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542840.3 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017792 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_047426975.1 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_017017790 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_047426981.1 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542844.4 | chr11:g.108253957C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542840 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| NM_000051.3 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| XM_011542843.3 | chr11:g.108247060C>T | c.998C>T | p.S333F | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|